SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001171843-16-010052
Filing Date
2016-05-13
Accepted
2016-05-13 17:15:26
Documents
42
Period of Report
2016-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q f10q_051316p.htm 10-Q 237266
2 EXHIBIT 31.1 exh_311.htm EX-31.1 6054
3 EXHIBIT 31.2 exh_312.htm EX-31.2 6085
4 EXHIBIT 32.1 exh_321.htm EX-32.1 5961
  Complete submission text file 0001171843-16-010052.txt   1735610

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE FILE xbit-20160331.xml EX-101.INS 210410
6 XBRL SCHEMA FILE xbit-20160331.xsd EX-101.SCH 22948
7 XBRL CALCULATION FILE xbit-20160331_cal.xml EX-101.CAL 20352
8 XBRL DEFINITION FILE xbit-20160331_def.xml EX-101.DEF 173972
9 XBRL LABEL FILE xbit-20160331_lab.xml EX-101.LAB 157638
10 XBRL PRESENTATION FILE xbit-20160331_pre.xml EX-101.PRE 186877
Mailing Address 8201 E. RIVERSIDE DRIVE BUILDING 4, SUITE 100 AUSTIN TX 78744
Business Address 8201 E. RIVERSIDE DRIVE BUILDING 4, SUITE 100 AUSTIN TX 78744 512-386-2930
XBiotech Inc. (Filer) CIK: 0001626878 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37347 | Film No.: 161649517
SIC: 2834 Pharmaceutical Preparations